Condition

Relapsed or Refractory Follicular Lymphoma (1)

Overall Status

Recruiting (1)

Sign in for free

Phase

phase 3 (1)

Sponsor

Hoffmann-La Roche (1)

Collaborator

Intervention

lenalidomide (1)

mosunetuzumab (1)

rituximab (1)

tociluzumab (1)

Study Documents

Intervention Type

drug (1)

Funder Type

Industry (1)

Study Type

Interventional (1)

relapsed or refractory follicular lymphoma

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Relapsed or Refractory Follicular Lymphoma Trial in Worldwide (Mosunetuzumab, Lenalidomide, Rituximab)

Recruiting

Relapsed or Refractory Follicular Lymphoma

Mosunetuzumab
+3 more

Duarte, California
+108 more

Jul 26, 2022